HK1040717A1 - 用於治療脂代謝紊亂的與膽汁酸相連的丙醇胺類衍生物 - Google Patents

用於治療脂代謝紊亂的與膽汁酸相連的丙醇胺類衍生物 Download PDF

Info

Publication number
HK1040717A1
HK1040717A1 HK02102338.5A HK02102338A HK1040717A1 HK 1040717 A1 HK1040717 A1 HK 1040717A1 HK 02102338 A HK02102338 A HK 02102338A HK 1040717 A1 HK1040717 A1 HK 1040717A1
Authority
HK
Hong Kong
Prior art keywords
compound
alkyl
bond
acid
amino acid
Prior art date
Application number
HK02102338.5A
Other languages
English (en)
Chinese (zh)
Inventor
S‧斯坦格林
A‧恩森
H‧格罗姆毕克
W‧卡拉默
E‧法尔克
H‧格羅姆畢克
E‧法爾克
Original Assignee
萨诺费－阿文蒂斯德国有限公司
薩諾費-阿文蒂斯德國有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 萨诺费－阿文蒂斯德国有限公司, 薩諾費-阿文蒂斯德國有限公司 filed Critical 萨诺费－阿文蒂斯德国有限公司
Publication of HK1040717A1 publication Critical patent/HK1040717A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK02102338.5A 1998-10-02 1999-09-18 用於治療脂代謝紊亂的與膽汁酸相連的丙醇胺類衍生物 HK1040717A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19845403.1 1998-10-02
DE19845403A DE19845403B4 (de) 1998-10-02 1998-10-02 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PCT/EP1999/006930 WO2000020437A1 (de) 1998-10-02 1999-09-18 Mit gallensäuren verknüpfte propanolaminderivate zur behandlung von lipidstoffwechselstörungen

Publications (1)

Publication Number Publication Date
HK1040717A1 true HK1040717A1 (zh) 2002-06-21

Family

ID=7883185

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102338.5A HK1040717A1 (zh) 1998-10-02 1999-09-18 用於治療脂代謝紊亂的與膽汁酸相連的丙醇胺類衍生物

Country Status (22)

Country Link
US (1) US6180618B1 (https=)
EP (1) EP1117676B1 (https=)
JP (1) JP4598953B2 (https=)
KR (1) KR20010075511A (https=)
CN (1) CN1227259C (https=)
AR (1) AR035003A1 (https=)
AT (1) ATE273991T1 (https=)
AU (1) AU757366B2 (https=)
BR (1) BR9915019A (https=)
CA (1) CA2346085A1 (https=)
DE (2) DE19845403B4 (https=)
DK (1) DK1117676T3 (https=)
ES (1) ES2226440T3 (https=)
HK (1) HK1040717A1 (https=)
HU (1) HUP0103570A3 (https=)
ID (1) ID29353A (https=)
PL (1) PL347106A1 (https=)
PT (1) PT1117676E (https=)
RU (1) RU2234512C2 (https=)
TR (1) TR200100897T2 (https=)
WO (1) WO2000020437A1 (https=)
ZA (1) ZA200102586B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
US7161008B2 (en) * 2002-05-03 2007-01-09 Sanofi - Aventis Deutschland GmbH Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them
GB0213669D0 (en) * 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892341A7 (fi) 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
GB2250634A (en) * 1990-12-04 1992-06-10 Marconi Gec Ltd Point contact diodes
NZ240846A (en) 1990-12-06 1994-04-27 Hoechst Ag Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
JP2616845B2 (ja) * 1991-02-21 1997-06-04 清水化学株式会社 システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
DK0557879T3 (da) * 1992-02-22 1997-06-16 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse
TW289021B (https=) * 1993-05-08 1996-10-21 Hoechst Ag
EP0624593A3 (de) 1993-05-08 1995-06-07 Hoechst Ag Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
DK0869121T3 (da) * 1997-04-04 2004-09-20 Aventis Pharma Gmbh Hypolipidæmiske propanolaminderivater

Also Published As

Publication number Publication date
HUP0103570A3 (en) 2003-01-28
DE19845403B4 (de) 2005-02-10
ID29353A (id) 2001-08-23
BR9915019A (pt) 2001-08-14
EP1117676B1 (de) 2004-08-18
DE59910300D1 (de) 2004-09-23
TR200100897T2 (tr) 2001-10-22
PT1117676E (pt) 2004-11-30
PL347106A1 (en) 2002-03-25
DK1117676T3 (da) 2004-12-20
CN1321166A (zh) 2001-11-07
EP1117676A1 (de) 2001-07-25
AR035003A1 (es) 2004-04-14
WO2000020437A1 (de) 2000-04-13
ZA200102586B (en) 2001-10-03
HUP0103570A2 (hu) 2002-02-28
JP4598953B2 (ja) 2010-12-15
RU2234512C2 (ru) 2004-08-20
ATE273991T1 (de) 2004-09-15
JP2002526550A (ja) 2002-08-20
AU6085599A (en) 2000-04-26
KR20010075511A (ko) 2001-08-09
AU757366B2 (en) 2003-02-20
US6180618B1 (en) 2001-01-30
ES2226440T3 (es) 2005-03-16
CN1227259C (zh) 2005-11-16
DE19845403A1 (de) 2000-04-13
CA2346085A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
CA2345369C (en) Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
HK1040717A1 (zh) 用於治療脂代謝紊亂的與膽汁酸相連的丙醇胺類衍生物
US6596728B1 (en) Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use
CZ20011151A3 (cs) Deriváty propanolaminu vázané s kyselinou žlučovou pro léčení poruch metabolismu lipidů
MXPA01003207A (en) Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism
MXPA01003145A (en) Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof
CN101443349A (zh) 作为通道活化蛋白酶抑制剂的化合物和组合物
CN101578120A (zh) 作为通道活化蛋白酶抑制剂的化合物和组合物